Anti-angiogenic effects of liposomal prednisolone phosphate on B16 melanoma in mice.

[1]  M. Battaglia,et al.  Platelet Factor 4 Differentially Modulates CD4+CD25+ (Regulatory) versus CD4+CD25− (Nonregulatory) T Cells1 , 2005, The Journal of Immunology.

[2]  R. Schiffelers,et al.  Liposome-encapsulated prednisolone phosphate inhibits growth of established tumors in mice. , 2005, Neoplasia.

[3]  G. Burmester,et al.  Glucocorticoids in the treatment of rheumatic diseases: an update on the mechanisms of action. , 2004, Arthritis and rheumatism.

[4]  J. Cidlowski,et al.  Mechanisms of glucocorticoid receptor signaling during inflammation , 2004, Mechanisms of Ageing and Development.

[5]  R. Kofler,et al.  Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance , 2004, Cell Death and Differentiation.

[6]  L. Hefler,et al.  Monocyte Chemoattractant Protein-1 Serum Levels in Patients with Breast Cancer , 2004, Tumor Biology.

[7]  Hsiu‐Po Wang,et al.  Interleukin-6 increases vascular endothelial growth factor and angiogenesis in gastric carcinoma. , 2004, Journal of biomedical science.

[8]  P. Claudio,et al.  Molecular basis of angiogenesis and cancer , 2003, Oncogene.

[9]  M. Gougerot-Pocidalo,et al.  Regulation of Interleukin 12 p40 and p70 Production by Blood and Alveolar Phagocytes During Severe Sepsis , 2003, Laboratory Investigation.

[10]  M. Wauben,et al.  Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes. , 2003, Arthritis and rheumatism.

[11]  Manoj Kumar Gupta,et al.  Mechanism and its regulation of tumor-induced angiogenesis. , 2003, World journal of gastroenterology.

[12]  C. Hogaboam,et al.  C-C Chemokine Ligand 2/Monocyte Chemoattractant Protein-1 Directly Inhibits NKT Cell IL-4 Production and Is Hepatoprotective in T Cell-Mediated Hepatitis in the Mouse1 , 2003, The Journal of Immunology.

[13]  S. Kiselev,et al.  Molecular Mechanisms of Tumor Angiogenesis , 2003, Biochemistry (Moscow).

[14]  S. Bayramov.  Concentration Oscillations in Three-Component Reaction Systems , 2003, Biochemistry (Moscow).

[15]  E. van Marck,et al.  Arterio-venous gradients of IL-6, plasma and serum VEGF and D-dimers in human cancer , 2002, British Journal of Cancer.

[16]  A. Amsterdam,et al.  Cell-specific regulation of apoptosis by glucocorticoids: implication to their anti-inflammatory action. , 2002, Biochemical pharmacology.

[17]  M. Stack,et al.  Tumor production of angiostatin is enhanced after exposure to TNF‐α , 2002, International journal of cancer.

[18]  A. Santoni,et al.  Production of MCP-1 and RANTES in bladder cancer patients after bacillus Calmette-Guerin immunotherapy , 2002, Cancer Immunology, Immunotherapy.

[19]  B. Mroczko,et al.  Granulocyte-Colony Stimulating Factor (G-CSF) and Macrophage-Colony Stimulating Factor (M-CSF) in Colorectal Cancer Patients , 2002, Clinical chemistry and laboratory medicine.

[20]  C. Ruhrberg,et al.  Endogenous inhibitors of angiogenesis. , 2001, Journal of cell science.

[21]  R. Huang,et al.  Detection of multiple proteins in an antibody-based protein microarray system. , 2001, Journal of immunological methods.

[22]  G. Clayman,et al.  Chemokines in cancer , 2001, Expert Reviews in Molecular Medicine.

[23]  J. Ward,et al.  Eotaxin (CCL11) Induces In Vivo Angiogenic Responses by Human CCR3+ Endothelial Cells1 , 2001, The Journal of Immunology.

[24]  C. Wahlestedt,et al.  Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Renauld,et al.  Interleukin-9 (IL-9) induces cell growth arrest associated with sustained signal transducer and activator of transcription activation in lymphoma cells overexpressing the IL-9 receptor. , 2001, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[26]  J. Ajioka,et al.  Toxoplasma gondii genomics: shedding light on pathogenesis and chemotherapy , 2001, Expert Reviews in Molecular Medicine.

[27]  P. Salgame,et al.  Rescue of human T cells by interleukin-9 (IL-9) from IL-2 deprivation-induced apoptosis: correlation with alpha subunit expression of the IL-9 receptor. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[28]  M. Kuwano,et al.  Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: Possible involvement of TNFα and IL‐1α , 2000 .

[29]  K. W. Kim,et al.  Identification of angiogenic properties of insulin-like growth factor II in in vitro angiogenesis models , 2000, British Journal of Cancer.

[30]  G. Otsuka,et al.  Inhibition of Nuclear Factor-κB Activation Confers Sensitivity to Tumor Necrosis Factor-α by Impairment of Cell Cycle Progression in Human Glioma Cells , 1999 .

[31]  N. Mitsiades,et al.  Fas ligand expression in thyroid carcinomas: a potential mechanism of immune evasion. , 1999, The Journal of clinical endocrinology and metabolism.

[32]  R. Salgado,et al.  Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients , 1999, British Journal of Cancer.

[33]  P. Dentelli,et al.  Thrombopoietin stimulates endothelial cell motility and neoangiogenesis by a platelet-activating factor-dependent mechanism. , 1999, Circulation research.

[34]  H. Young,et al.  Differential regulation of the Janus kinase-STAT pathway and biologic function of IL-13 in primary human NK and T cells: a comparative study with IL-4. , 1998, Journal of immunology.

[35]  R. Townley,et al.  Glucocorticoids inhibit proliferation and interleukin-4 and interleukin-5 secretion by aeroallergen-specific T-helper type 2 cell lines. , 1998, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[36]  J. Lotem,et al.  Different mechanisms for suppression of apoptosis by cytokines and calcium mobilizing compounds. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[37]  G. Camussi,et al.  Development of Inflammatory Angiogenesis by Local Stimulation of Fas In Vivo , 1997, The Journal of experimental medicine.

[38]  D. Willoughby,et al.  The codependence of angiogenesis and chronic inflammation , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[39]  G. Viglietto,et al.  Role of soluble mediators in angiogenesis. , 1996, European journal of cancer.

[40]  B. Beutler,et al.  The tumor necrosis factor ligand and receptor families. , 1996, The New England journal of medicine.

[41]  G. Neufeld,et al.  Interleukin 6 Induces the Expression of Vascular Endothelial Growth Factor (*) , 1996, The Journal of Biological Chemistry.

[42]  R. Hoffman,et al.  Basic fibroblast growth factor promotes the proliferation of human megakaryocyte progenitor cells. , 1993, Blood.

[43]  G. Reifferscheid,et al.  Detection of mammalian carcinogens with an immunological DNA synthesis-inhibition test. , 1992, Carcinogenesis.

[44]  A. Mantovani,et al.  Monocyte chemotactic cytokine gene transfer modulates macrophage infiltration, growth, and susceptibility to IL-2 therapy of a murine melanoma. , 1991, Journal of immunology.

[45]  D. Scudiero,et al.  Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. , 1988, Cancer research.

[46]  J. Adamson,et al.  Interleukin 1 stimulates human endothelial cells to produce granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor. , 1987, Journal of immunology.

[47]  J. Adamson,et al.  Tumor necrosis factor type alpha stimulates human endothelial cells to produce granulocyte/macrophage colony-stimulating factor. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[48]  S. Fleischer,et al.  Two dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots , 1970, Lipids.

[49]  G. Otsuka,et al.  Inhibition of nuclear factor-kappaB activation confers sensitivity to tumor necrosis factor-alpha by impairment of cell cycle progression in human glioma cells. , 1999, Cancer research.

[50]  A. Kolk,et al.  Measurement of antigen specific lymphocyte proliferation using 5-bromo-deoxyuridine incorporation. An easy and low cost alternative to radioactive thymidine incorporation. , 1991, Journal of immunological methods.

[51]  G. L. Peterson.  Determination of total protein. , 1983, Methods in enzymology.